A 70-year-old man presented with abdominal pain. Enhanced CT revealed a hypodense mass with peripheral enhancement in the pancreatic body ([Picture 1](#g001){ref-type="fig"}). Endoscopic ultrasonography confirmed a well-defined hypoechoic mass measuring 20 mm in size ([Picture 2](#g002){ref-type="fig"}). Endoscopic retrograde pancreatography showed a smooth narrowing of the pancreatic duct with displacement ([Picture 3](#g003){ref-type="fig"}). Surgical resection was performed. The resected specimen measured 20×18 mm in size with a thick fibroid capsule. The histopathological results confirmed it to be undifferentiated carcinoma, with osteoclast-like giant cells (UCOGC) and no vascular invasion ([Picture 4](#g004){ref-type="fig"}). There had been no further recurrence for over five years following surgery.
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UCOGC is a rare pancreatic malignancy that has been reported to have a more favorable prognosis than pancreatic ductal adenocarcinoma ([@B1]). The good outcome in such patients might be attributable to following factors. The presence of osteoclast-like giant cells has been associated with an improved prognosis ([@B2]). In addition, the small tumor size and encapsulation may increase the survival period for such cases.
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